Abstract
Polycystic ovary syndrome (PCOS) is a complex, common endocrine condition affecting reproductive aged women with a reported prevalence of between 8 and 13%, depending on the diagnostic criteria and the population studied. Diagnosis, based on Rotterdam criteria, commonly requires two of the three following features: oligo/amenorrhoea, polycystic ovaries on ultrasound, biochemical/or clinical hyperandrogenism, with exclusion of other aetiologies. Nurses are ideally situated to provide evidence-based care and education within an interdisciplinary model to optimise the health outcomes of women with PCOS.
PCOS affects health and well-being over the lifespan. The presentation of PCOS can be heterogeneous with reproductive (hyperandrogenism, anovulation, and subfertility), metabolic (dyslipidaemia, type 2 diabetes, and CVD risk factors), and psychological features (depression, anxiety, and poor self-esteem). Women with PCOS are also predisposed to weight gain, which in turn increases PCOS prevalence and exacerbates its severity. PCOS is underpinned by intrinsic insulin resistance. Obesity exacerbates insulin resistance, and lifestyle modification alleviates this feature.
Despite the high prevalence of PCOS many women with PCOS remain undiagnosed, clinical practice is inconsistent, psychological issues are neglected, and there is little focus on lifestyle modification and chronic disease prevention with most services targeting fertility and offering costly assisted reproductive technology. In addition, women report dissatisfaction with diagnosis experiences, poor quality information, and inadequate support.
Given the multi-system dimensions of PCOS and duration of impact over the lifespan, PCOS places a large financial burden on health systems with affected women also suffering the social costs of stigmatisation and isolation, largely due to non-conformity with societal expectations relating to femininity and fecundity. In addition, due to the diversity of PCOS health impacts, affected women may be marginalised within the health system and often fall between the gaps in a speciality-focused health care system, with knowledge gaps among practitioners and, inconsistency in care delivered. In the primary care sector, health practitioners report feeling confused and ill equipped to manage PCOS, listing PCOS as the highest priority for education in women’s health. With women feeling isolated, disempowered, and underserviced, PCOS places a personal burden on affected women and their significant others, and highlights the lack of systemic, evidence-based responsiveness to their needs. This chapter provides an overview of PCOS for endocrine nurses who can play a critical role in providing evidence-based, person-centred care, within an interdisciplinary, biopsychosocial model of care.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AMH:
-
Anti-Müllerian hormone
- BMI:
-
Body mass index
- FAI:
-
Free androgen index
- FSH:
-
Follicle stimulating hormone
- GnRH:
-
Gonadotropin-releasing hormone
- LH:
-
Luteinising hormone
- OGTT:
-
Oral glucose tolerance test
- PCOS:
-
Polycystic ovary syndrome
- SHBG:
-
Sex hormone binding globulin
- T:
-
Testosterone
References
Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metabol. 2005;90(8):4650–8.
Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nature reviews Disease primers. 2016;2:16057.
Barnard L, Ferriday D, Guenther N, Strauss B, Balen A, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–86.
Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–83.
Boyle JACJ, O’Dea K, Dunbar T, Norman RJ. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin. Australia. Med J Aust. 2012;196(1):62–6.
Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13(6):1502–5.
Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107(6):1380–6.e1.
Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metabol. 2017;102(2):604–12.
Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):773–88.
Jason J. Polycystic ovary syndrome in the United States: clinical visit rates, characteristics, and associated health care costs. Arch Intern Med. 2011;171(13):1209–11.
Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt). 2015;24(4):299.
Kahsar-Miller M, Azziz R. The development of the polycystic ovary syndrome: family history as a risk factor. Trends in Endocrinology & Metabolism. 1998;9(2):55–8.
Legro SR, Arslanian AS, Ehrmann AD, Hoeger MK, Murad HM, Pasquali KR, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol. 2013;98(12):4565–92.
Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. 2013. p. 95–109.
March WA, Moore VM, Willson KJ, Phillips DIW, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544–51.
Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013;28(8):2276–83.
Palomba S, de Wilde MA, Falbo A, Koster MPH, La Sala GB, Fauser BCJM. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575.
Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777–84.
Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BGA, Wong JLA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195(6):S65.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526–32.
Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1812–6.
Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067–73.
Yilmaz B, Vellanki P, Ata B, Yildiz BO. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2018;109(2):356.
Key Reading
International evidence-based guideline for the assessment and management of polycystic ovary syndrome. Copyright Monash University; 2018. (Link to be provided); https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline.
Shorakae S, Boyle J, Teede H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Intern Med J. 2014;44(8):720–6.
Legro SR, Arslanian AS, Ehrmann AD, Hoeger MK, Murad HM, Pasquali KR, et al. diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–92.
Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28–38.e25.
Dokras A. Improving care for women with polycystic ovary syndrome. Fertil Steril. 2018;110(1):50–1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Garad, R., Shorakae, S., Teede, H. (2019). Assessment and Management of Women with Polycystic Ovary Syndrome (PCOS). In: Llahana, S., Follin, C., Yedinak, C., Grossman, A. (eds) Advanced Practice in Endocrinology Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-99817-6_39
Download citation
DOI: https://doi.org/10.1007/978-3-319-99817-6_39
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99815-2
Online ISBN: 978-3-319-99817-6
eBook Packages: MedicineMedicine (R0)